MISSION THERAPEUTICS LTD has a total of 188 patent applications. It decreased the IP activity by 62.0%. Its first patent ever was published in 2013. It filed its patents most often in United Kingdom, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are CUMBRE PHARMACEUTICALS INC, MITOKININ INC and CERMOL SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 52 | |
#2 | United States | 27 | |
#3 | WIPO (World Intellectual Property Organization) | 24 | |
#4 | EPO (European Patent Office) | 21 | |
#5 | China | 19 | |
#6 | Australia | 5 | |
#7 | Canada | 5 | |
#8 | Brazil | 4 | |
#9 | Israel | 4 | |
#10 | Republic of Korea | 4 | |
#11 | Singapore | 4 | |
#12 | Colombia | 3 | |
#13 | Hong Kong | 3 | |
#14 | Mexico | 3 | |
#15 | South Africa | 3 | |
#16 | Japan | 2 | |
#17 | Taiwan | 2 | |
#18 | Argentina | 1 | |
#19 | Hungary | 1 | |
#20 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Kemp Mark Ian | 93 |
#2 | Stockley Martin Lee | 85 |
#3 | Jones Alison | 67 |
#4 | Madin Andrew | 55 |
#5 | Woodrow Michael David | 24 |
#6 | Whitlock Gavin Alistair | 22 |
#7 | Stockley Martin | 21 |
#8 | Gibson Karl Richard | 21 |
#9 | Kemp Mark | 21 |
#10 | Gibson Karl | 17 |
Publication | Filing date | Title |
---|---|---|
GB202101935D0 | Novel compounds | |
GB202016800D0 | Novel compounds | |
GB202016785D0 | Novel compounds | |
GB202016791D0 | Novel compounds | |
GB202016758D0 | Novel compounds | |
GB202016713D0 | Novel compounds | |
GB202016689D0 | Novel compounds | |
GB202016709D0 | Novel compounds | |
GB202016607D0 | Novel Compounds | |
GB202016527D0 | Novel compounds | |
GB202010335D0 | Novel Compounds | |
GB202010349D0 | Novel Compounds | |
GB202005250D0 | Novel compounds | |
GB201915129D0 | Novel compounds | |
GB201912836D0 | Novel compounds | |
GB201912674D0 | Novel compounds | |
GB201905371D0 | Novel compounds | |
GB201905375D0 | Novel compounds | |
CN110831936A | Substituted cyanopyrrolidines with DUB inhibitor activity | |
GB201803568D0 | Novel compounds and uses |